KFBIO Celebrates 13 Years of Innovation in Digital Pathology

Building a Strong Foundation in Pathology

Founded in 2011, KFBIO is a national high-tech enterprise dedicated to pathology innovation. Over the past 13 years, the company has grown into one of China’s leading providers of integrated digital pathology solutions.

KFBIO offers a comprehensive portfolio that includes digital pathology products, pathology information systems, AI pathology solutions, laboratory pre-processing equipment, and pathology testing services. Together, these technologies help healthcare institutions improve diagnostic efficiency and accelerate digital transformation.

Driven by Talent and Innovation

Chairman Liu Bingxian founded KFBIO with a team of experienced researchers and industry experts. Many core team members have international research, development, and management experience. They have also received recognition through national and regional talent programs.

Today, KFBIO employs more than 320 people. Around 63% of employees hold a bachelor’s degree or above, including 31 professionals with master’s or doctoral degrees. This talented team continues to drive the company’s research and innovation.

Strengthening Research and Intellectual Property

Innovation has always been at the heart of KFBIO’s growth. To date, the company has applied for more than 380 patents and software copyrights, with over 230 already authorized.

In addition, KFBIO operates a provincial high-tech R&D center and a provincial postdoctoral workstation. The company has also established research centers in Hangzhou, Shanghai, and Nanjing.

Moreover, KFBIO works closely with leading research institutes and renowned medical institutions. These collaborations accelerate technological innovation and support the continuous development of smarter digital pathology solutions.

Recognized Across the Industry

KFBIO’s commitment to innovation has earned widespread industry recognition. Over the years, the company has received more than 50 national, provincial, and municipal awards.

These honors include recognition as a National “Little Giant” Enterprise, a National Intellectual Property Advantage Enterprise, a Zhejiang Hidden Champion Enterprise, and the recipient of the First Prize of the Jiangsu Science and Technology Award. These achievements reflect KFBIO’s continued leadership in digital pathology innovation.

Driving Innovation Through Continuous Research

Innovation has always been a core part of KFBIO’s development strategy. Over the years, the company has continuously invested in research and development to advance digital pathology technologies.

Today, KFBIO has built a strong R&D team that includes experienced scientists and senior engineers from around the world. Their expertise drives continuous product improvement and supports the company’s long-term innovation goals.

As technology evolves, KFBIO continues to expand its product portfolio. What began with a single product line has grown into a comprehensive range of solutions for pathology diagnosis, digital pathology, AI-assisted diagnosis, and laboratory automation.

These innovations have enabled KFBIO to deliver end-to-end digital pathology solutions that help laboratories improve workflow efficiency, strengthen quality control, and support more accurate diagnoses.

Delivering Reliable Products and Trusted Services

Product quality remains a top priority at KFBIO. Every product undergoes rigorous design, testing, and quality control before it reaches customers.

This commitment to quality helps laboratories achieve reliable performance and consistent diagnostic results. It has also earned the trust of customers around the world.

In addition to high-quality products, KFBIO continues to improve its customer service experience. The company listens closely to customer feedback and regularly enhances its service processes to meet evolving laboratory needs.

Meanwhile, KFBIO’s sales and after-sales teams provide timely technical support and professional assistance whenever customers need help. Their responsive service helps laboratories maintain efficient operations and maximize the value of KFBIO’s digital pathology solutions.

Growing Together with Our Partners

Strong partnerships have played an important role in KFBIO’s growth over the past 13 years.

The company believes that long-term success comes from collaboration and shared value. Therefore, KFBIO works closely with partners across the healthcare industry to promote innovation and support the continued development of digital pathology.

Through these collaborations, KFBIO continues to expand its global network while creating new opportunities for customers, partners, and the pathology community.

Looking Ahead

As KFBIO celebrates its 13th anniversary, the company looks to the future with confidence and a clear vision for continued growth.

Innovation will remain at the center of KFBIO’s development strategy. The company will continue to invest in research and development, explore new technologies, and deliver innovative products that support the future of pathology.

At the same time, KFBIO will further enhance its digital pathology solutions by combining advanced hardware, AI-powered software, and intelligent laboratory automation. These innovations will help laboratories improve workflow efficiency, strengthen quality management, and deliver more accurate diagnostic results.

Customer success will also remain a top priority. KFBIO will continue to improve its products, optimize its services, and provide reliable technical support to meet the evolving needs of hospitals, laboratories, and research institutions.

Meanwhile, the company will strengthen collaboration with partners around the world. By working together, KFBIO aims to accelerate digital transformation in pathology and create greater value for the global healthcare community.

Thank You for Growing with Us

Over the past 13 years, every milestone has been made possible by the trust and support of our customers, partners, employees, and industry colleagues.

We sincerely thank everyone who has been part of KFBIO’s journey. Your encouragement and collaboration continue to inspire us to innovate and grow.

Looking ahead, KFBIO remains committed to advancing digital pathology through innovation, collaboration, and high-quality solutions. We look forward to creating the next chapter together with customers and partners around the world.

Explore KFBIO’s Digital Pathology Solutions

KFBIO provides end-to-end digital pathology solutions for hospitals, laboratories, research institutes, and healthcare organizations worldwide.

Our product portfolio includes:

• Digital Pathology Scanners
• AI Pathology Solutions
• Pathology Information Systems
• Whole Slide Imaging (WSI) Solutions
• Laboratory Automation Equipment
• Digital Pathology Workflow Solutions

Together, these solutions help laboratories improve efficiency, enhance diagnostic accuracy, and accelerate digital transformation.

Ready to learn more?

Contact KFBIO to discover how our integrated digital pathology solutions can support your laboratory’s future development.

FAQ

What does KFBIO specialize in?

KFBIO specializes in digital pathology, AI pathology, pathology information systems, laboratory automation, and integrated pathology solutions.

How long has KFBIO been developing digital pathology solutions?

Founded in 2011, KFBIO has more than 13 years of experience in digital pathology innovation.

What products does KFBIO provide?

KFBIO offers digital pathology scanners, AI pathology software, pathology information systems, laboratory automation equipment, and whole slide imaging solutions.

How does KFBIO support pathology laboratories?

KFBIO helps laboratories improve workflow efficiency, strengthen quality control, and enhance diagnostic accuracy through integrated digital pathology solutions.